(1R,3S)-3-(((BENZYLOXY)CARBONYL)AMINO)CYCLOHEXYL ACETATE, 95.0%, 5g

Di(pyridin-3-yl)methanamine, 98%, 1g

Morpholino(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methanone, 95.0%, 5g

Cyclopentanecarboxylic acid, 97.0%, 50g

2-Amino-4-(trifluoromethyl)pyrimidine>98.0%(GC)(T)1g

Methyl 3-(chlorosulfonyl)propanoate, 97.0%, 10g

Screw vials conical sterile, 0.5 ml, 200 Piece(s)

(R)-2-Amino-2-(naphthalen-2-yl)ethanol hydrochloride, 97.0%, 250mg

7-Chloro-4-methoxy-2,3-dihydro-1H-inden-1-one, 97.0%, 250mg

(S)-1-(4-(1H-Pyrazol-4-yl)phenyl)-2-amino-1-(4-chlorophenyl)ethanol, 95.0%, 25mg

Di-tert-butyl 2-(hydroxymethyl)piperazine-1,4-dicarboxylate, 95.0%, 250mg

tert-Butyl (2-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)carbamate, 95%, 5g

(R)-2-((tert-butoxycarbonyl)amino)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoic acid, 97%, 1g